These final results, along with a preceding report displaying that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 assistance the principle of focusing on ACKR3 as a unique approach to modulate the opioid process, which could open new therapeutic avenues for opio